Quarter
Charts🇺🇸US Markets

BioCorRx Inc.

BICX

CIK 0001443863 · Quarterly mode · latest period FY2025 (Q3) (ending 2025-09-30) · sourced from SEC EDGAR

At a glance · FY2025 (Q3)

Revenue
$635K
Gross Profit
$635K

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
50/100
  • Profitability
    100ROIC 30.9% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.10 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.16x (1.0+ = capital-efficient)
  • Growth
    0Insufficient data
  • Margin Trend
    100Op Margin -306.3% · trend +29707.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
—
investment in PP&E
Stock-based comp (TTM)
$351K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$2M
everything owned
Total liabilities
$14M
everything owed
Stockholders' equity
$-11M
shareholder claim
Net debt
$-111K
Net cash position ($111K)

Recent performance · 62 quarters

Revenue
$635K
Net Income↓-28.9% -$430K
$-2M
Free Cash Flow↓-103.0% -$350K
$-690K
Operating Margin
-306.3%

Drill down

BICX Sankey

See BioCorRx Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

BICX Charts

62 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

BICX Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics